Document Detail

IL-6 predicts organ dysfunction and mortality in patients with multiple injuries.
Jump to Full Text
MedLine Citation:
PMID:  19781105     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Although therapeutic concepts of patients with major trauma have improved during recent years, organ dysfunction still remains a frequent complication during clinical course in intensive care units. It has previously been shown that cytokines are upregulated under stress conditions such as trauma or sepsis. However, it is still debatable if cytokines are adequate parameters to describe the current state of trauma patients. To elucidate the relevance of cytokines, we investigated if cytokines predict development of multiple organ dysfunction syndrome (MODS) or outcome.
METHODS: A total of 143 patients with an injury severity score >or= 16, between 16 and 65 years, admitted to the Hannover Medical School Level 1 Trauma Center between January 1997 and December 2001 were prospectively included in this study. Marshall Score for MODS was calculated for at least 14 days and plasma levels of TNF-alpha, IL-1beta, IL-6, IL-8 and IL-10 were measured. To determine the association between cytokine levels and development of MODS the Spearman rank correlation coefficient was calculated and logistic regression and analysis were performed.
RESULTS AND DISCUSSION: Patients with MODS had increased plasma levels of IL-6, IL-8 and IL-10. IL-6 predicted development of MODS with an overall accuracy of 84.7% (specificity: 98.3%, sensitivity: 16.7%). The threshold value for development of MODS was 761.7 pg/ml and 2176.0 pg/ml for mortality during the in patient time.
CONCLUSION: We conclude that plasma IL-6 levels predict mortality and that they are a useful tool to identify patients who are at risk for development of MODS.
Authors:
Michael Frink; Martijn van Griensven; Philipp Kobbe; Thomas Brin; Christian Zeckey; Bernhard Vaske; Christian Krettek; Frank Hildebrand
Related Documents :
14676235 - Raised concentrations of macrophage colony stimulating factor in severe unstable angina...
11153885 - Autonomic failure after stroke--is it indicative for pathophysiology of complex regiona...
21051895 - Can high-sensitivity c-reactive protein and plasma homocysteine levels independently pr...
10850345 - Disease stage prognostic indices in the early clinical screening of colorectal cancer p...
9349335 - A prospective longitudinal study of the outdoor behaviour and symptoms of photosensitiv...
19929425 - Chromosome instability in patients with chronic renal failure.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-27
Journal Detail:
Title:  Scandinavian journal of trauma, resuscitation and emergency medicine     Volume:  17     ISSN:  1757-7241     ISO Abbreviation:  Scand J Trauma Resusc Emerg Med     Publication Date:  2009  
Date Detail:
Created Date:  2009-10-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101477511     Medline TA:  Scand J Trauma Resusc Emerg Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  49     Citation Subset:  IM    
Affiliation:
Trauma Department, Hannover Medical School, Hannover, Germany. michaelfrink@web.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Scand J Trauma Resusc Emerg Med
ISSN: 1757-7241
Publisher: BioMed Central
Article Information
Download PDF
Copyright © 2009 Frink et al; licensee BioMed Central Ltd.
open-access: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received Day: 14 Month: 5 Year: 2009
Accepted Day: 27 Month: 9 Year: 2009
collection publication date: Year: 2009
Electronic publication date: Day: 27 Month: 9 Year: 2009
Volume: 17First Page: 49 Last Page: 49
ID: 2763001
Publisher Id: 1757-7241-17-49
PubMed Id: 19781105
DOI: 10.1186/1757-7241-17-49

IL-6 predicts organ dysfunction and mortality in patients with multiple injuries
Michael Frink1 Email: michaelfrink@web.de
Martijn van Griensven2 Email: Martijn.van.Griensven@LBITRAUMA.ORG
Philipp Kobbe3 Email: Kobbe.Philipp@gmx.de
Thomas Brin1 Email: brin.thomas@mh-hannover.de
Christian Zeckey1 Email: zeckey.christian@mh-hannover.de
Bernhard Vaske4 Email: vaske.bernhard@mh-hannover.de
Christian Krettek1 Email: krettek@compuserve.com
Frank Hildebrand1 Email: hildebrand.frank@mh-hannover.de
1Trauma Department, Hannover Medical School, Carl-Neuberg-Str 1, 30625 Hannover, Germany
2Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Donaueschingenstraße 13, A-1200 Vienna, Austria
3Department of Trauma Surgery, University Hospital Essen, Hufelandstr 55, 45122 Essen, Germany
4Center for Biometry, Hannover Medical School, Carl-Neuberg-Str 1, 30625 Hannover, Germany

Background

During the last decades, improvement of therapeutic concepts has decreased trauma related fatalities [1]. Organ dysfunction is still a frequent and severe complication during clinical course and the most common cause for late fatalities following major trauma. Although the survival rate of patients with multiple injuries improved during the last decades the frequency of development of organ dysfunction has not changed [2,3]. The mortality of patients developing multiple organ dysfunction syndrome (MODS) following severe injuries is still 50% [4-6]. For adequate treatment, it would be desirable to identify patients with a high risk for posttraumatic complications in the early clinical course. The evaluation of clinical state and prognosis still remains one of the greatest challenges during treatment of patients suffering from multiple injuries. Many clinical parameters such as blood pressure, pH or heart rate failed to assess the posttraumatic situation [7].

Several clinical studies have demonstrated that increased cytokine plasma levels are correlated with MODS, severity of injury, as well as mortality [8-13]. While plasma IL-6 levels were able to predict outcome in a murine sepsis model [14], the data in humans is still controversial [12,15-17]. Thus, it was the purpose of our study to correlate plasma cytokine levels with MODS and mortality and determine threshold values of these cytokines for development of MODS. We hypothesized that plasma cytokines levels can predict MODS and mortality in humans following major trauma. To test this hypothesis we correlated plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-α as well as traditional parameters such as lactate, platelets and base excess with MODS and mortality.


Methods
Inclusion and exclusion criteria

Polytraumatized patients between the ages of 16 and 65 years who were admitted to Hannover Medical School Level 1 Trauma Center between January 1997 and December 2001 were prospectively included in this study. Patients with an injury severity score <16 points were excluded. In addition, patients with a history of steroid use, anti-inflammatory treatment or hormone replacement therapy were excluded. Patients with malignancies or chronic diseases of the liver, kidneys or lung were also excluded (Table 1).

Ethical approval and informed consent

The study was approved by the Ethical Committee of the Hannover Medical School, Hannover, Germany. Informed consent was obtained from all patients (or their relatives) included in this study.

Pattern and severity of injury

Additionally, the abbreviated injury scale was determined after a trauma scan (CT scan of head, cervical spine, thorax, abdomen and pelvis) and severity of injury was calculated using the injury severity score (ISS).

Clinical parameter and outcome evaluation

Patients were carefully examined at 7 AM and blood (10 ml) was daily collected for routine analysis and cytokine measurement (TNF-α, IL-1β, IL-6, IL-8, IL-10). Plasma cytokines were determined using a commercially available kit (Immulite® System: Random Access Immunoassay Analyser; DPC-Biermann, Bad Nauheim, Germany) following the manufacturer's instructions. The results of clinical examination and blood chemistry (C-reactive protein [CRP], platelets, lactate and base excess) were recorded up to 14 days after admission (Table 2).

Diagnosis of sepsis was made according to the criteria of the Consensus Conference of the American College of Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) [18] on at least two consecutive days [19]. MODS was diagnosed using the score of Marshall et al [20]. This score has been shown to be the most reliable score for diagnosis of MODS [21]. As previously described, a manifest MODS was considered when the score was >12 points on two consecutive days or at least three days during the observed period [22].

Patient management and treatment

After admission, all patients received an arterial and a central venous line. A standardized clinical examination, a focused assessment with sonography for trauma (FAST) and at least chest and pelvic x-rays were performed. After diagnostics in the emergency room, a trauma scan (CT-scan of head, cervical spine, chest, abdomen and pelvis) was accomplished. Results were analyzed by an attending radiologist and an attending trauma surgeon. At time of admission to the intensive care unit (ICU), the clinical examination and FAST were repeated. Included patients were treated by physicians who are not involved in this study.

Subgroup analysis

Depending on fulfillment of the MODS criteria, patients were divided into two groups, those with and without multiple organ dysfunction syndrome (MODS, no MODS).

Statistics

Statistical analysis was performed using SPSS, version 15 (SPSS, Chicago, IL, USA). Results from descriptive analyses are expressed as mean ± standard error of the mean. Statistical significance was assumed where probability values p of less than 0.05 were obtained. Comparison between groups was performed using one-way analysis of variances (ANOVA) followed by the Tukey test. The Spearman rank correlation coefficient was used to determine the connection between cytokine levels and development of MODS. Additionally we performed an analysis of the relationship between the plasma cytokine concentrations and complications using logistic regression for identifying relevant parameters as well as a receiver operating characteristic (ROC) curve analysis for validation of Il-6 as a predictive marker.


Results
Demographics

A total of 143 patients (106 males and 37 females) were included in this study. Age and ISS were comparable in all analyzed subgroups. Additional characteristics are shown in Table 1.

Pattern and severity of injury

Pattern and severity of injury were comparable in all analyzed groups. Furthermore, injury severity and pattern described by AIS (abbreviated injury scale; data not shown) and ISS (Table 1) showed no significant difference in all analyzed subgroups.

MODS influence on plasma cytokines
TNF-α

While plasma levels of TNF-α were comparable on day 1 in patients with and without MODS, a steady increase was observed in the MODS group (p < 0.05).

IL-1β

During the observed period, MODS did not influence plasma levels of IL-1β (p > 0.05).

IL-6

During the entire observation period, patients with MODS had higher plasma levels of IL-6 than patients without MODS. Differences were more distinct during the first week (p < 0.05).

IL-8

Plasma levels of IL-8 were significantly higher in MODS patients than in patients who did not have MODS with a distinct difference at day 1 (p < 0.05).

IL-10

MODS patients had increased plasma levels of IL-10 on days 1 to 3 and days 9 to 14 compared with patients without MODS (p < 0.05).

MODS influence on other plasma parameters
CRP

MODS patients had increased plasma CRP levels on days 4 to 14 (p < 0.05).

Platelets

During the entire observation period, patients with MODS had higher platelet counts than patients without MODS (p < 0.05).

Lactate

Patients with organ dysfunction had higher plasma lactate levels as compared to patients with uneventful recovery on days 1 to 14 (p < 0.05).

Base excess

Base excess was elevated in patients with MODS on days 2, 3 and 13 (p < 0.05).

Correlation between cytokines and MODS

Besides IL-1β all analyzed cytokines showed a significant correlation between cytokine plasma concentration and development of MODS. The correlation coefficients for all analyzed cytokines are shown in Table 2.

Correlation between laboratory values and MODS

All tested parameters correlated with development of MODS (see Table 3).

Sensitivity, specificity and overall accuracy

For all cytokines with a correlation coefficient >0.26, sensitivity, specificity and overall accuracy were calculated. The sensitivity for IL-8, IL-10, TNF-α, CRP and base excess was 0%. The specificity of IL-6 was 98.3% while sensitivity was only 16.7% (overall accuracy 84.7%). Combination of IL-6 with platelets and lactate improved sensitivity and specificity (Table 3).

Critical value of IL-6 for MODS development

Since IL-6 was the best parameter for predicting the development of posttraumatic MODS we calculated a threshold value at which the probability of MODS development is >50%. At a plasma IL-6 concentration of 761.7 pg/μl, >50% patients developed MODS. Injury pattern and severity is shown in Table 4.

Prognostic value of IL-6 for mortality in the early clinical course

At day 1 plasma IL-6 levels had a specificity of 100% while the sensitivity was 28.6%. The overall accuracy was 86.1%. At day 2, similar values were detected (specificity: 97.8%, sensitivity: 19.0%, overall accuracy: 83.2%) The IL-6 threshold value for mortality during the in-patient time was 2176.0 pg/ml.

ROC curve analysis

The ROC curve analysis for IL-6 for predicting MODS and mortality are shown in Fig. 1. The areas under the curve for MODS and mortality are, respectively, 0.874 (SE 0.03; 95% confidence interval [CI] 0.8110.937), 0.858 (SE 0.05; 95% CI 0.759-0.956).


Discussion

As previously published, we have investigated the plasma levels of common parameters (CRP, platelets, lactate and base excess) and various cytokines such as TNF-α, IL-1β, IL-6, IL-8, and IL-10 in patients suffering from major trauma[13] Besides IL-1β, all cytokines showed higher levels in patients matching the MODS criteria and correlated with MODS. Patients with MODS had no greater severity of injury or a different injury pattern [13]. IL-6 not only showed the best correlation but predicted development of MODS with an overall accuracy of 84.7%. In addition, IL-6 was the best parameter in predicting mortality (overall accuracy 86.1% at day 1 and 83.2% at day 2).

The fact that patients with MODS had higher cytokine plasma levels is consistent with our previously published results in the same population as well as observations from other investigators [8,12,13,15,23]. However, to the best of our knowledge, this is the first study providing a threshold value of IL-6 for development of organ dysfunction and mortality.

The authors are aware of the limitations of the present study due to an inhomogeneous population. There are several factors influencing systemic cytokine levels (i.e. number of blood transfusions, gender, genetic polymorphisms) that cannot be controlled due to the design of the study [13,24,25].

Since trauma has a huge socioeconomic impact [26] and sepsis and MODS increase costs of treatment in trauma patients [27] it is necessary to identify patients susceptible for development of MODS in early clinical course to adjust therapeutic interventions. The concept of damage control surgery is based on studies investigating further damage by operations in the early clinical phase [10]. Though the outcome of patients has improved during recent years, defined parameters predicting posttraumatic complications are still lacking.

The present study shows increased plasma IL-6 levels in patients with MODS as compared to patients with uneventful recovery. These findings confirm studies from other investigators [12,15]. However, in several studies a correlation between IL-6 and MODS was not proven [16,17]. Since in both studies only 16 and 13 patients, respectively, were included lack of a correlation between plasma IL-6 levels and MODS could be due to the small number of patients. In the present study, IL-6 was the best parameter for predicting development of MODS as compared to other cytokines. Since IL-6 had the highest specificity and overall accuracy we calculated a threshold value above which the development of MODS is likely. This critical value may be of high relevance in further treatment of polytraumatized patients. In the present study, we showed that IL-6 predicts outcome in patients following major trauma. Thus, we confirmed studies from a murine septic shock model showing that IL-6 predicts outcome in the early phase of sepsis [14,28]. In humans, a correlation between high plasma IL-6 levels and outcome was shown in pediatric patients with major head injury [29]. Martin et al. showed that elevated plasma levels were associated with fatal outcome in septic shock stage [30]. Additionally, increased IL-6 values were an indicator of the development of a nosocomial infection in trauma patients. However, to our knowledge this is the first study describing a critical value of IL-6 for development of MODS and predicting mortality.

Patients matching the MODS criteria had higher plasma IL-8 levels than patients without complications. We could determine a correlation between systemic IL-8 concentrations and the MODS score. This finding is in accordance with data from other investigators who also show an association between organ dysfunction and increased plasma IL-8 levels in patients with major injury [11]. Furthermore, patients with established diagnosis of adult respiratory distress syndrome, a common posttraumatic complication [31], showed elevated IL-8 levels in bronchoalveolar lavage fluid [8]. In the performed logistic regression analysis, we could show a correlation between MODS and IL-8 levels, but IL-8 was not able to identify patients suffering from MODS. Thus, IL-8 seems not to be an adequate parameter regarding the development of MODS. Since IL-8 showed an association to thoracic trauma [8,9] its role in this particular injury needs to be evaluated in further studies.

In the present study patients with MODS had higher IL-10 plasma levels in the early clinical course. Elevated systemic IL-10 levels correlated with MODS but were not of value predicting the development of organ failure. Neidhard et al. showed that increased plasma IL-10 levels are not only associated with posttraumatic complications but also with severity of injury [23]. Since IL-10 is an anti-inflammatory cytokine, elevated levels can be estimated as a compensatory anti-inflammatory response to prevent possible harmful hyperinflammation.

Although IL-10 levels were increased in patients with MODS, studies have shown that elevated levels may contribute to augmented organ dysfunction in trauma patients [32]. However, IL-10 failed to predict development of organ dysfunction in the present study.

Patients with MODS did not have higher levels of IL-1β as compared to patients without MODS. This is in accordance with findings from other studies in which IL-1-β was not increased during response to septic shock secondary to generalized peritonitis [33]. Contrary to these results, other investigators proved an association between IL-1β and with an increased mortality rate and an increased risk for subsequent ARDS and MOF in patients following major vascular surgery, trauma or hemorrhagic shock [12]. These conflicting results may be due to the short half-life (6 min) of this mediator [34]. However, our results indicate that IL-1β is not correlated with MODS and is therefore not a useful parameter for predicting posttraumatic organ dysfunction.

In the present study, patients suffering from organ dysfunction had increased plasma TNF-α levels as compared to patients without MODS. Similar results were shown by other investigators for trauma patients [35], as well as in burn patients [36]. Although there is an association between TNF-α and MODS, this pro-inflammatory cytokine failed to predict development of MODS investigated in the logistic regression analysis.

As previously described, the traditional parameters for describing the status of patients following trauma or with major surgery were associated with organ dysfunction [7,37,38]. Although all investigated parameters failed to predict mortality or development of MODS, in combination with IL-6, they improved the sensitivity, specificity and overall accuracy as compared to IL-6 alone. Although secretion of CRP is induced by IL-6[39] in the present study, CRP failed to correlate with the development of MODS.


Conclusion

In the current study we demonstrated the correlation between various cytokines and MODS in polytraumatized patients. We determined a threshold value for IL-6 for predicting development of MODS and predicting mortality. This will help to identify patients in the early clinical period who are susceptible to develop organ dysfunction. This is important insofar as these patients require special therapeutic concepts such as damage control surgery.


List of abbrevations

ARDS: adult respiratory distress syndrome; CRP: C-reactive protein; IL: interleukin; ISS: injury severity score; ml: millilitre; MOF: multi organ failure; MODS: multi organ dysfunction syndrome; pg: picograme; TNF: tumor necrosis factor


Conflict of interests

The authors declare that they have no competing interests.


Acknowledgements

The authors thank Bobbi Smith for editing. Part of this project was performed as a doctoral thesis of T.B. at Hannover Medical School. This study was supported by a HILF grant of the Hannover Medical School Hannover.


References
Regel G,Grotz M,Weltner T,Sturm JA,Tscherne H. Pattern of organ failure following severe traumaWorld J Surg 1996;20:422–429. [pmid: 8662130] [doi: 10.1007/s002689900067]
Sauaia A,Moore FA,Moore EE,Norris JM,Lezotte DC,Hamman RF. Multiple organ failure can be predicted as early as 12 hours after injuryJ Trauma 1998;45:291–301. [pmid: 9715186] [doi: 10.1097/00005373-199808000-00014]
Sauaia A,Moore FA,Moore EE,Lezotte DC. Early risk factors for postinjury multiple organ failureWorld J Surg 1996;20:392–400. [pmid: 8662125] [doi: 10.1007/s002689900062]
Durham RM,Moran JJ,Mazuski JE,Shapiro MJ,Baue AE,Flint LM. Multiple organ failure in trauma patientsJ Trauma 2003;55:608–616. [pmid: 14566110] [doi: 10.1097/01.TA.0000092378.10660.D1]
Nast-Kolb D,Aufmkolk M,Rucholtz S,Obertacke U,Waydhas C. Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple traumaJ Trauma 2001;51:835–841. [pmid: 11706328] [doi: 10.1097/00005373-200111000-00003]
Soreide K,Kruger AJ,Vardal AL,Ellingsen CL,Soreide E,Lossius HM. Epidemiology and contemporary patterns of trauma deaths: changing place, similar pace, older faceWorld J Surg 2007;31:2092–2103. [pmid: 17899256] [doi: 10.1007/s00268-007-9226-9]
Waydhas C,Nast-Kolb D,Trupka A,Zettl R,Kick M,Wiesholler J,et al. Posttraumatic inflammatory response, secondary operations, and late multiple organ failureJ Trauma 1996;40:624–630. [pmid: 8614044] [doi: 10.1097/00005373-199604000-00018]
Aggarwal A,Baker CS,Evans TW,Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndromeEur Respir J 2000;15:895–901. [pmid: 10853855] [doi: 10.1034/j.1399-3003.2000.15e14.x]
Keel M,Ecknauer E,Stocker R,Ungethum U,Steckholzer U,Kenney J,et al. Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest traumaJ Trauma 1996;40:907–912. [pmid: 8656476] [doi: 10.1097/00005373-199606000-00008]
Pape HC,Hildebrand F,Pertschy S,Zelle B,Garapati R,Grimme K,et al. Changes in the management of femoral shaft fractures in polytrauma patients: from early total care to damage control orthopedic surgeryJ Trauma 2002;53:452–461. [pmid: 12352480] [doi: 10.1097/00005373-200209000-00010]
Partrick DA,Moore FA,Moore EE,Biffl WL,Sauaia A,Barnett CC Jr. Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failureAm J Surg 1996;172:425–429. [pmid: 8942538] [doi: 10.1016/S0002-9610(96)00252-8]
Roumen RM,Hendriks T,van der Ven-Jongekrijg J,Nieuwenhuijzen GA,Sauerwein RW,van der Meer JW,et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failureAnn Surg 1993;218:769–776. [pmid: 8257227] [doi: 10.1097/00000658-199312000-00011]
Frink M,Pape HC,van Griensven M,Krettek C,Chaudry IH,Hildebrand F. Influence of sex and age on mods and cytokines after multiple injuriesShock 2007;27:151–156. [pmid: 17224789] [doi: 10.1097/01.shk.0000239767.64786.de]
Remick DG,Bolgos GR,Siddiqui J,Shin J,Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 daysShock 2002;17:463–467. [pmid: 12069181] [doi: 10.1097/00024382-200206000-00004]
Bahrami S,Redl H,Yao YM,Schlag G. Involvement of bacteria/endotoxin translocation in the development of multiple organ failureCurr Top Microbiol Immunol 1996;216:239–258. [pmid: 8791743]
Law MM,Cryer HG,Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patientsJ Trauma 1994;37:100–109. [pmid: 7913140] [doi: 10.1097/00005373-199407000-00017]
Lendemans S,Kreuzfelder E,Waydhas C,Nast-Kolb D,Flohe S. [Clinical course and prognostic significance of immunological and functional parameters after severe trauma]Unfallchirurg 2004;107:203–210. [pmid: 14999368] [doi: 10.1007/s00113-004-0729-7]
Bone RC,Balk RA,Cerra FB,Dellinger RP,Fein AM,Knaus WA,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineChest 1992;101:1644–1655. [pmid: 1303622] [doi: 10.1378/chest.101.6.1644]
Talmor M,Hydo L,Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitationArch Surg 1999;134:81–87. [pmid: 9927137] [doi: 10.1001/archsurg.134.1.81]
Marshall JC,Cook DJ,Christou NV,Bernard GR,Sprung CL,Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcomeCrit Care Med 1995;23:1638–1652. [pmid: 7587228] [doi: 10.1097/00003246-199510000-00007]
Grotz M,von Griensven M,Stalp M,Kaufmann U,Hildebrand F,Pape HC. [Scoring multiple organ failure after severe trauma. Comparison of the Goris, Marshall and Moore scores]Chirurg 2001;72:723–730. [pmid: 11469095] [doi: 10.1007/s001040170130]
Marshall JC,Cook DJ,Christou NV,Bernard GR,Sprung CL,Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcomeCrit Care Med 1995;23:1638–1652. [pmid: 7587228] [doi: 10.1097/00003246-199510000-00007]
Neidhardt R,Keel M,Steckholzer U,Safret A,Ungethuem U,Trentz O,et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patientsJ Trauma 1997;42:863–870. [pmid: 9191668] [doi: 10.1097/00005373-199705000-00017]
Sperry JL,Friese RS,Frankel HL,West MA,Cuschieri J,Moore EE,et al. Male gender is associated with excessive IL-6 expression following severe injuryJ Trauma 2008;64:572–578. [pmid: 18332795] [doi: 10.1097/TA.0b013e3181650fdf]
Hildebrand F,Pape HC,van Griensven M,Meier S,Hasenkamp S,Krettek C,et al. Genetic predisposition for a compromised immune system after multiple traumaShock 2005;24:518–522. [pmid: 16317381] [doi: 10.1097/01.shk.0000184212.97488.4e]
Westhoff J,Hildebrand F,Grotz M,Richter M,Pape HC,Krettek C. Trauma care in GermanyInjury 2003;34:674–683. [pmid: 12951292] [doi: 10.1016/S0020-1383(03)00147-5]
O'Keefe GE,Maier RV,Diehr P,Grossman D,Jurkovich GJ,Conrad D. The complications of trauma and their associated costs in a level I trauma centerArch Surg 1997;132:920–924. [pmid: 9267280]
Manley MO,O'Riordan MA,Levine AD,Latifi SQ. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcomeShock 2005;23:521–526. [pmid: 15897804]
Chiaretti A,Genovese O,Aloe L,Antonelli A,Piastra M,Polidori G,et al. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcomeChilds Nerv Syst 2005;21:185–193. [pmid: 15455248] [doi: 10.1007/s00381-004-1032-1]
Martin C,Boisson C,Haccoun M,Thomachot L,Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe traumaCrit Care Med 1997;25:1813–1819. [pmid: 9366763] [doi: 10.1097/00003246-199711000-00018]
White TO,Jenkins PJ,Smith RD,Cartlidge CW,Robinson CM. The epidemiology of posttraumatic adult respiratory distress syndromeJ Bone Joint Surg Am 2004;86-A:2366–2376. [pmid: 15523005]
Khadaroo RG,Fan J,Powers KA,Fann B,Kapus A,Rotstein OD. Impaired induction of IL-10 expression in the lung following hemorrhagic shockShock 2004;22:333–339. [pmid: 15377888] [doi: 10.1097/01.shk.0000136095.96306.08]
Riche FC,Cholley BP,Panis YH,Laisne MJ,Briard CG,Graulet AM,et al. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitisCrit Care Med 2000;28:433–437. [pmid: 10708179] [doi: 10.1097/00003246-200002000-00024]
Lin E,Calvano SE,Lowry SF. Inflammatory cytokines and cell response in surgerySurgery 2000;127:117–126. [pmid: 10686974] [doi: 10.1067/msy.2000.101584]
Menges T,Engel J,Welters I,Wagner RM,Little S,Ruwoldt R,et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complicationsCrit Care Med 1999;27:733–740. [pmid: 10321662] [doi: 10.1097/00003246-199904000-00026]
Zhang B,Huang YH,Chen Y,Yang Y,Hao ZL,Xie SL. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patientsBurns 1998;24:599–603. [pmid: 9882056] [doi: 10.1016/S0305-4179(98)00091-6]
Hao J,Lei M,Zhang Y,Zhang P,Sun CJ,Bian GY,et al. [Dynamic changes of platelet number in early multiple injury and it is effect on prognosis]Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003;15:615–617. [pmid: 14552687]
Singhal R,Coghill JE,Guy A,Bradbury AW,Adam DJ,Scriven JM. Serum lactate and base deficit as predictors of mortality after ruptured abdominal aortic aneurysm repairEur J Vasc Endovasc Surg 2005;30:263–266. [pmid: 15936225] [doi: 10.1016/j.ejvs.2005.04.003]
Haider DG,Leuchten N,Schaller G,Gouya G,Kolodjaschna J,Schmetterer L,et al. C-reactive protein is expressed and secreted by peripheral blood mononuclear cellsClin Exp Immunol 2006;146:533–539. [pmid: 17100775] [doi: 10.1111/j.1365-2249.2006.03224.x]

Figures

[Figure ID: F1]
Figure 1 

ROC curve analysis of IL-6 for the prediction of MODS (A) and mortality (B).



Tables
[TableWrap ID: T1] Table 1 

Demographic data of included patients; *p < 0.05 MODS vs. No MODS.


Parameter MODS No MODS All patients
Patients [n] 24 119 143
Age [years] 40.0 ± 3.6 36.3 ± 1.4 36.9 ± 1.3
Sex [m:f] 7:1* 2.5:1 2.9:1
GCS 9.0 ± 1.0 10.5 ± 0.5 10.2 ± 0.4
ISS 28.5 ± 2.1 24.5 ± 0.7 25.1 ± 0.7
Mortality [%] 54.2 6.7 14.7

[TableWrap ID: T2] Table 2 

Correlation coefficient of laboratory parameters and development of MODS.


Parameter Correlation coefficient
IL-1β 0.00
IL-6 0.35*
IL-8 0.53*
IL-10 0.31*
TNF-α 0.32*
CRP 0.27*
Platelets -0.32*
Lactate 0.37*
Base Excess 0.11*

* p < 0.01


[TableWrap ID: T3] Table 3 

Specifity, sensitivity and accuracy of laboratory markers.


Parameter Specificity Sensitivity Overall accuracy
IL-6 98.3% 16.7% 84.7%*
IL-8 n.d. n.d. n.d.
IL-10 n.d. n.d. n.d.
TNF-α n.d. n.d. n.d.
CRP n.d. n.d. n.d.
Platelets 98.3% 8.3% 83.2%*
Lactate 99.1% 8.7% 83.9%*
Base Excess n.d. n.d. n.d.
IL-6+Lactate 97% 17% 84.7%*
IL-6+Platelets 98% 21% 84.6%*
IL-6+Lactate+Platelets 97% 26% 85.4%*

[TableWrap ID: T4] Table 4 

Injury pattern and severity of patients with systemic IL-6 levels above the critical value for the development of MODS.


AIShead/neck AISface AISchest AISabdomen AISExtremity AISsoft tissue ISS
2.8 ± 1.1 0 ± 0 3.5 ± 0.8 3.0 ± 1.3 3.0 ± 0.4 1.0 ± 0.0 28.2 ± 11.9


Article Categories:
  • Original Research


Previous Document:  Chromosome territories, X;Y translocation and Premature Ovarian Failure: is there a relationship?
Next Document:  Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding.